Avermectin市场－2026-2031年预测

Avermectin市场预计将从 2025 年的 6.7447 亿美元成长到 2031 年的 8.58989 亿美元，复合年增长率为 4.11%。

Avermectin（也称为阿维菌素）是一种广泛使用的杀虫剂和驱虫剂。它属于Avermectin类化合物，是土壤微生物发酵的天然产物。其有效性体现在接触后3-4天内即可迅速控制目标昆虫。此外，Avermectin具有连锁反应效应，可透过昆虫族群间的接触和食物共用传播毒素，从而根除整个虫群和寄生虫族群。

人类和动物健康应用

在人类健康领域，伊维菌素（一种Avermectin衍生物）用于治疗由多种寄生虫、犬心丝虫和头蝨引起的感染疾病。Avermectin市场依应用领域划分，涵盖杀虫剂、药品、动物用药品及其他用途。按应用领域划分，市场既包括人类应用，也包括兽医应用。伊维菌素已核准用于人类，可对抗寄生虫、蝨子和皮肤病（如酒糟）引起的感染疾病。经美国食品药物管理局 (FDA)核准的伊维菌素片剂用于治疗由寄生虫引起的肠道圆线虫病和盘尾丝虫病。兽用伊维菌素製剂核准用于预防犬心丝虫病以及治疗某些体内外寄生虫。如此广泛的用途和多样化的应用，充分展现了Avermectin及其衍生物在人类和动物健康领域的多功能性和重要性。

市场成长驱动因素

全球人口成长是推动农业发展的主要成长要素。全球人口的快速成长意味着扩大农业生产至关重要。随着人类努力满足快速增长的人口需求，有效的病虫害防治已成为关键因素，不仅关乎数百万面临饥饿的人们的福祉，也关乎世界各国经济的永续增长和长期繁荣。

随着全球粮食安全成为首要任务，加强农业实践的重要性日益凸显。Avermectin因其对多种作物（从水果蔬菜到棉花和咖啡）中多种害虫的频谱活性而脱颖而出，成为一种极具价值的防治工具。对于寻求可靠作物保护的农民而言，Avermectin提供了一个符合全球人口粮食需求挑战的解决方案。使用Avermectin不仅有助于提高农业生产力，而且有望为全球永续经济成长奠定坚实基础。

多学科应用正在推动市场扩张。Avermectin的影响范围已从农业扩展到包括兽医学和公共卫生在内的多个领域。在兽医学领域，它被用作牲畜和伴侣动物的寄生虫控制药物。它在治疗体内外寄生虫方面发挥着重要作用，例如蜱虫、跳蚤和蝨子，并能预防动物疾病和不适，从而显着改善动物的健康和福祉。

在公共卫生领域，Avermectin在控制疟疾和淋巴丝虫病等媒介传播疾病方面发挥着重要作用，其针对携带疾病的蚊子的有效性显着改善了公共卫生结果。

Avermectin在白蚁防治方面也具有实际应用价值，是保护木质结构和建筑物的可靠手段。这项应用展现了Avermectin的多功能性，它不仅适用于农业领域，还能应对动物健康、公共卫生和结构保护等更广泛的挑战。其用途广泛，且在这些领域的需求不断增长，凸显了其重要性和市场供应的充足性。

市场约束

监管管理是一项挑战。不断变化的监管环境，尤其是各地对农药使用和基准值日益严格的限制，给行业内的市场准入和产品开发带来了重大障碍。

欧盟委员会于2023年1月颁布的法规就是一个具体的例子。该法规对某些水果和蔬菜设定了新的最高残留基准值。苹果、梨子、草莓、番茄、黄瓜、木瓜和榅桲的基准值要求大幅降低。这项法规的特殊之处在于，它于2023年8月20日即时生效，没有任何过渡期。如此严格的监管措施正在显着限制市场的成长。

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

第五章Avermectin市场：依应用领域划分

• 介绍
• 杀虫剂
• 製药
• 兽医
• 其他的

第六章Avermectin市场：依剂型划分

• 介绍
• 药片
• 粉末
• 液体

第七章Avermectin市场：依应用领域划分

• 介绍
• 对人类而言
• 动物

第八章Avermectin市场：按地区划分

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• Solutions Pest & Lawn
• Albaugh LLC.
• Merck KGaA, Darmstadt
• Forestry Distributing a Horizon Company.
• RayBiotech, Inc.
• Zagro
• Kaiser Foundation Health Plan, Inc.
• MedSpace
• Seed World
• Control Solutions, Inc.

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

Abamectin Market, with a 4.11% CAGR, is forecasted to expand from USD 674.470 million in 2025 to USD 858.989 million in 2031.

Abamectin, also recognized as avermectin, demonstrates widespread usage as an insecticide and anthelmintic. Belonging to the avermectin family, Abamectin represents a natural fermentation product originating from soil-dwelling microorganisms. Its effectiveness manifests through swift elimination of target insects within 3 to 4 days upon contact. Additionally, Abamectin showcases a domino effect, eradicating entire colonies or infestations by spreading poison through contact or food sharing among insect populations.

Human and Animal Health Applications

In human health contexts, Ivermectin, an Abamectin derivative, serves as treatment for infections caused by various parasitic worms, threadworms, and head lice. The abamectin market, categorized by application, spans insecticides, drugs, veterinary products, and other uses. Market delineation by usage encompasses both human and animal applications. Ivermectin, specifically approved for human use, addresses infections resulting from parasitic worms, head lice, and skin conditions including rosacea. FDA-approved Ivermectin tablets treat individuals with intestinal strongyloidiasis and onchocerciasis, conditions caused by parasitic worms. Animal forms of Ivermectin find approval for preventing heartworm disease and treating specific internal and external parasites. This comprehensive utilization and varied applications underscore the versatility and significance of Abamectin and its derivatives in both human and animal health sectors.

Market Growth Drivers

Rising global population constitutes a primary driver. The escalating global population underscores imperatives for heightened agricultural production. As humanity strives meeting demands of burgeoning populations, effective pest control emerges as pivotal element ensuring not only well-being of millions facing hunger but also sustainable economic growth and long-term prosperity of nations worldwide.

Global food security takes center stage, with necessity to bolster agricultural practices becoming increasingly apparent. Abamectin, with its expansive spectrum of activity against myriad pests spanning diverse crops from fruits and vegetables to cotton and coffee, stands out as invaluable tool. Farmers, pursuing reliable crop protection, find in Abamectin a solution aligning with imperatives to address challenges of feeding growing global populations. Abamectin utilization contributes not only to agricultural productivity but also holds potential to fortify foundations of sustainable economic growth on global scales.

Multiple sector applications drive market expansion. Abamectin's impact transcends agricultural realms, branching into various sectors with applications in veterinary medicine and public health initiatives. In veterinary medicine, it serves as tool for controlling parasites in both livestock and companion animals. Its role treating internal and external parasites contributes significantly to enhancing animal health and welfare, addressing issues including ticks, fleas, and lice, thereby preventing diseases and discomfort in animals.

In public health spheres, Abamectin emerges as key player combatting vector-borne diseases, notably malaria and lymphatic filariasis. Its effectiveness targeting mosquitoes, which serve as disease carriers, plays important roles in improving public health outcomes.

Abamectin finds practical use in termite control, serving as reliable means of safeguarding wooden structures and buildings. This application underscores Abamectin versatility, not only in agricultural settings but also addressing broader concerns related to animal health, public health, and structural protection. Diverse applications and growing demand for Abamectin across these various sectors highlight its significance and widespread market utilization.

Market Constraints

Regulatory control presents challenges. The evolving regulatory landscape is characterized by increasingly stringent regulations on pesticide use and residue levels in various regions, presenting formidable challenges for market access and product development within the industry.

An illustrative example comes from EU Commission regulation in January 2023, imposing new maximum residue levels for select fruit varieties and vegetables. Notable reductions in limits have been mandated for apples, pears, strawberries, tomatoes, cucumbers, papayas, and quinces. What distinguishes this development is implementation immediacy, as new limits were enforced from August 20, 2023, without transition period provision. Such stringent regulatory measures pose considerable constraints on market growth trajectories.

Market Segmentation

The Abamectin market segments by form into Tablets, Powder, and Liquid, each catering to specific user preferences and requirements. Tablets, designed for pre-measured usage, provide advantages by ensuring precise and consistent application rates. Powdered Abamectin emerges as cost-friendly option, particularly appealing to budget-conscious users. Liquid formulations enhance versatility, with some available in ready-to-use spray bottles or cartridges. This feature facilitates targeted application to specific areas or pests, offering users flexibility and convenience addressing unique pest control needs.

Regional Market Leadership

North America is anticipated to hold significant Abamectin market share, propelled by multiple factors. North America's expansive agricultural terrain solidifies its prominence, featuring vast lands dedicated to cultivating arrays of crops including cotton, fruits, vegetables, and nuts. Abamectin emerges as crucial solution effectively managing and controlling these pests, due to high demand for pest control solutions prevalent in the region, contributing significantly to flourishing Abamectin market positioning.

Product Portfolio

Contemporary offerings reflect diverse application requirements. Ivermectin is available in 6 mg tablet form under the brand name Stromectol as generic medicine. Primarily, this medication is prescribed for treating specific parasitic roundworm infections, holding particular significance for those with weakened immune systems.

Control Solutions Inc. offers Abamectin 0.15 EC delivering management of mites and leafminers, exerting control over whiteflies, thrips, and aphids on various plants including foliage plants, woody ornamentals, and Christmas trees. Its effectiveness extends to combat ranges of pests, with active ingredient of 1.9% Abamectin providing targeted and potent pest control approaches.

Seed World offers Lucid Miticide Insecticide, a potent solution with Abamectin as its generic avid, standing out as highly effective for controlling mites and leaf miners across different cultivation environments.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Abamectin Market Segmentation

By Application

• Insecticides
• Drug
• Veterinary
• Others

By Form

• Tablet
• Powder
• Liquid

By Usage

• Human
• Animal

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ABAMECTIN MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Insecticides
• 5.3. Drug
• 5.4. Veterinary
• 5.5. Others

6. ABAMECTIN MARKET BY FORM

• 6.1. Introduction
• 6.2. Tablet
• 6.3. Powder
• 6.4. Liquid

7. ABAMECTIN MARKET BY USAGE

• 7.1. Introduction
• 7.2. Human
• 7.3. Animal

8. ABAMECTIN MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Solutions Pest & Lawn
• 10.2. Albaugh LLC.
• 10.3. Merck KGaA, Darmstadt
• 10.4. Forestry Distributing a Horizon Company.
• 10.5. RayBiotech, Inc.
• 10.6. Zagro
• 10.7. Kaiser Foundation Health Plan, Inc.
• 10.8. MedSpace
• 10.9. Seed World
• 10.10. Control Solutions, Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations